RxSight (RXST) 2025 Earnings: What Investors Should Do
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
This article breaks down the key drivers behind global stock indices, including economic data, central bank policy, and market sentiment.
20,453 articlesRxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
Target just reported 13th quarter slump, prompting questions about management, costs, and the path to growth. Here ar...
A legendary investor makes a bold AI move. He recently closed a position in a company famous for aggressive AI spend ...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
Cerebras just pulled biggest IPO momentum sent shockwaves through tech stocks. This article breaks down what that imp...
Xcel Brands faces a pivotal year in 2025 as it leans on licensed partnerships and cost discipline. This guide outline...
A global memory crunch has propelled Micron to the forefront of AI-era investing. This article breaks down the why, w...
Palo Alto Networks is set to report fiscal Q3 after the close, with investors eyes on growth guidance and the CyberAr...
Walmart faces a pivotal moment as macro headwinds collide with a fast-growing digital ecosystem. This report examines...